TransMedics Group, Inc.

NasdaqGM:TMDX Stock Report

Market Cap: US$2.1b

TransMedics Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:TMDX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Aug 24SellUS$3,186,536James TobinIndividual20,000US$159.96
05 Jun 24SellUS$95,053Anil RanganathIndividual703US$135.21
05 Jun 24SellUS$164,729Edward BasileIndividual1,193US$138.08
29 May 24SellUS$282,540Stephen GordonIndividual2,000US$141.27
29 May 24SellUS$168,988David WeillIndividual1,193US$141.65
10 May 24SellUS$324,550David WeillIndividual2,500US$129.82
06 May 24SellUS$418,570Nicholas CorcoranIndividual3,222US$129.91
02 May 24SellUS$1,510,868Waleed HassaneinIndividual12,444US$122.67
01 May 24SellUS$5,697,903Tamer KhayalIndividual52,209US$123.66
08 Mar 24SellUS$115,409Tamer KhayalIndividual1,317US$87.63
08 Mar 24SellUS$166,760Stephen GordonIndividual1,903US$87.63

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TMDX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,016,3512.51%
Institutions39,520,41697.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.8%.


Top Shareholders

Top 25 shareholders own 81.95% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.8%
BlackRock, Inc.
5,307,759US$327.5m101%0.01%
13%
FMR LLC
4,363,161US$269.2m105%0.02%
10.7%
The Vanguard Group, Inc.
3,595,059US$221.8m42.3%no data
4.3%
Driehaus Capital Management LLC
1,442,207US$89.0m-2.95%0.53%
3.79%
State Street Global Advisors, Inc.
1,273,131US$78.6m62.6%no data
3.1%
Invesco Ltd.
1,041,517US$64.3m-19.8%0.02%
2.9%
ArrowMark Colorado Holdings, LLC
973,403US$60.1m-14.5%0.76%
2.67%
Macquarie Investment Management Business Trust
896,111US$55.3m-6.29%0.06%
2.41%
Lord, Abbett & Co. LLC
809,135US$49.9m51.6%0.15%
2.33%
Fidelity International Ltd
781,397US$48.2m107%0.02%
2.28%
Geode Capital Management, LLC
763,790US$47.1m1.34%no data
2.06%
Eventide Asset Management, LLC
690,632US$42.6m-39.7%0.74%
1.79%
Allspring Global Investments, LLC
599,116US$37.0m5.29%0.05%
1.43%
BNY Asset Management
480,379US$29.6m15.4%0.01%
1.43%
Mackenzie Financial Corporation
478,744US$29.5m-21.1%0.03%
1.4%
Waleed Hassanein
469,359US$29.0m0%no data
1.37%
Morgan Stanley, Investment Banking and Brokerage Investments
460,248US$28.4m-1.64%no data
1.36%
Fuller & Thaler Asset Management, Inc.
456,522US$28.2m15.2%0.11%
1.36%
1832 Asset Management L.P.
455,445US$28.1m0%0.04%
1.2%
UBS Asset Management AG
403,864US$24.9m3.33%no data
1.17%
Sandhill Capital Partners LLC
392,561US$24.2m-9.75%1.76%
1.05%
Goldman Sachs Group, Investment Banking and Securities Investments
352,362US$21.7m65.9%0.01%
1.03%
AHL Partners LLP
345,170US$21.3m0%0.19%
1.03%
Hood River Capital Management LLC
344,551US$21.3m175%0.32%
0.98%
Vaughan Nelson Investment Management, L.P.
329,010US$20.3m24.3%0.18%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:09
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TransMedics Group, Inc. is covered by 13 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David RescottBaird
William PlovanicCanaccord Genuity
Kristen StewartCL King & Associates, Inc.